Post
2026
AIRGO Kicks Off!
AIRGO designs and builds AI systems for businesses, the public sector and research teams. Scientifically grounded, explainable, and wrapped in…
Application domain
Pheochromocytomas and Paragangliomas
PPGL (Pheochromocytomas and Paragangliomas) refers to rare neuroendocrine tumors that can develop in the adrenal medulla or along the sympathetic nervous system. These tumors secrete catecholamines, causing symptoms like high blood pressure, headaches, and palpitations. While some PPGLs are benign, all have the potential to metastasize, and diagnosis often involves genetic testing, imaging, and measuring catecholamine metabolites. Treatment depends on the tumor's stage and molecular characteristics, and ongoing research focuses on targeted therapies for metastatic disease.
Research Project
2026
SFB/TRR 205 “The Adrenal: Central Relay in Health and Disease”, Project B12
Project B12 Neural-crest derived catecholamine producing tumours: implementation of molecular and metabolic fingerprints to predict disease progression and therapeutic response…
Post
2026
XAI Suite and Evidence-based AI validation tools
A cross-domain workbench for building, explaining and — critically — validating AI models before anyone trusts them. It couples model…
Post
2025
High-impact publication in eClinicalMedicine, part of THE LANCET
Utility of disease probability scores to guide decision-making during screening for phaeochromocytoma and paraganglioma: a machine learning modelling cross sectional…
Publication
2025
Utility of disease probability scores to guide decision-making during screening for phaeochromocytoma and paraganglioma: a machine learning modelling cross sectional study
eClinicalMedicine — Vol. 82, pp. 103181 10.1016/j.eclinm.2025.103181
No entries match your filters.
